We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: news

Behavioral Activation Reduces Perinatal Suicide Ideation: Insights from the SUMMIT Trial

MedXY Editorial Team•Oct 27, 2025•news
Behavioral ActivationMaternal Mental Healthperinatal depressionpsychotherapy

Introduction

Suicide remains a leading cause of maternal mortality in the postpartum period, underscoring a pressing need for effective, evidence-based interventions tailored for perinatal women. Perinatal depression, affecting both pregnant and postpartum individuals, often coexists with suicidal ideation (SI), posing significant risks to maternal and infant health. Behavioral activation (BA) psychotherapy, a structured intervention focusing on increasing engagement with rewarding and meaningful activities, has emerged as a promising treatment for depression, but its impact on perinatal suicide ideation requires further elucidation.

Study Background

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Psychotherapy for Impact of Killing During War: Advancing Treatment of PTSD and Moral Injury in VeteransThis review synthesizes evidence from a pivotal randomized clinical trial and complementary literature on psychotherapeutic interventions addressing the psychological impact of killing in war, emphasizing improvements in PTSD, moral injury,Aug 20, 2026Balancing Maternal Mental Health and Fetal Safety: Insights on Depression and SSRI Use During PregnancyThis article reviews the complex interplay between major depressive disorder during pregnancy and selective serotonin reuptake inhibitor treatment, highlighting the importance of prioritizing maternal mental health to optimize outcomes forAug 18, 2026Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression: The EPISODE Randomized Clinical TrialPsilocybin-assisted psychotherapy showed promising but inconclusive antidepressant effects in treatment-resistant depression, with notable acute adverse events and safety concerns.May 18, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Brief Psychological Intervention for Personality Disorder Shows No Benefit: Insights from the SPS Trial
A multicentre RCT in England demonstrates that a 10-session brief psychological intervention offers no significant improvement in social functioning or cost-effectiveness for individuals with probable personality disorder, reinforcing the n
Mar 2, 2026
Scalable Telephone-Based Behavioral and Mindfulness Interventions Effectively Reduce Long-Term Loneliness in At-Risk Older Adults: Insights from the HEAL-HOA TrialThe HEAL-HOA randomized clinical trial demonstrates that lay counselor-delivered telephone interventions using behavioral activation and mindfulness significantly and sustainably reduce loneliness and improve well-being among vulnerable, diFeb 5, 2026
Deciphering Prenatal Risks: Why Maternal Health, Not Medication, Often Drives Neurodevelopmental OutcomesRecent large-scale cohort studies suggest that previously observed links between prenatal exposure to acid-suppressants or antipsychotics and neurodevelopmental disorders are largely due to familial confounding. Conversely, active maternal Jan 25, 2026